Applications of CRISPR/Cas9 Technology in Translational Research on Solid-Tumor Cancers
Efforts Are Underway to Move CRISPR/Cas9 from Bench to Bedside
Repurposing of Kinase Inhibitors as Broad-Spectrum Antiviral Drugs
Summary of the Progress and Challenges in the Repurposing Kinase Inhibitors as Broad-Spectrum Antiviral Therapies
Genome Editing B.C. (Before CRISPR)
Lasting Lessons from the “Old Testament”
Crowdfunding for Science: Models of Best Practice
It’s Not Just the Science That Has to Be Memorable
Wendy Macias Ph.D.
More GEN Content From This Contributor
- Feature Articles: Marketing Analysis: What Is the Future of DTC Drug Advertising?